Application 084546
- Type
- ANDA
- Sponsor
- PERRIGO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A084546-001 | MEPROBAMATE | MEPROBAMATE | 200MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A084546-001 | MEPROBAMATE | 200MG | TABLET / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A084546-001 | MEPROBAMATE | 200MG | TABLET / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A084546-001 | MEPROBAMATE | 200MG | TABLET / ORAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meprobamate | MEPROBAMATE | Cipla USA Inc. | 17d814e2-b277-4dce-8615-e7fd7cab773f | 2026-07-08 | Warnings, Adverse reactions | Meprobamate MEPROBAMATE |
| MEPROBAMATE | MEPROBAMATE | Alembic Pharmaceuticals Limited | a0891a32-105b-48bc-a246-5e179d2e7fa1 | 2023-01-10 | Warnings, Adverse reactions | MEPROBAMATE MEPROBAMATE |
| Meprobamate | MEPROBAMATE | Alembic Pharmaceuticals Inc. | 3b255bcd-0218-44f8-830b-971f5ec45276 | 2021-10-01 | Warnings, Adverse reactions | Meprobamate MEPROBAMATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.